
Alert: New Earnings Report (8/8/24)-Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR).
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) has reported E.P.S. of $-1.38 for its third fiscal quarter (ending June 30) versus $-0.96 for the same period a year ago. This result fell short of the consensus estimate […]